Search Results - eileen+geoghegan

1 Results

Sort By:

Isolation and Application of a Llama-derived Single Domain Antibody Binding to Glycoprotein D of HSV-2

Treatment and Preventative for Herpes Simplex Virus-2JHU REF: 12627Invention Novelty: This technology is an antibody-toxin fusion therapeutic for treatment and prevention of HSV-2.Value Proposition:HSV infects 85% of the global population and 73% of the American population. Currently, there is no cure for HSV infection. This technology is an antibody-based...

Published: 3/13/2025 | Inventor(s): Eileen Geoghegan, Richard Markham

Keywords(s): Antibodies, Biologics, Disease Indication, Herpes Simplex Virus, Herpes Simplex Virus (HSV), Infectious Diseases, Therapeutic Matter, Therapeutic Substance, Therapeutics, Viral Infections

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > Herpes Simplex Virus, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Biologics, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities